These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 21072891)

  • 21. Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Kage M; Aishima S; Kusano H; Yano H
    J Med Ultrason (2001); 2020 Oct; 47(4):549-554. PubMed ID: 33136250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease.
    Murphy SK; Yang H; Moylan CA; Pang H; Dellinger A; Abdelmalek MF; Garrett ME; Ashley-Koch A; Suzuki A; Tillmann HL; Hauser MA; Diehl AM
    Gastroenterology; 2013 Nov; 145(5):1076-87. PubMed ID: 23916847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.
    Rastogi A; Shasthry SM; Agarwal A; Bihari C; Jain P; Jindal A; Sarin S
    APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.
    Liu F; Goh GB; Tiniakos D; Wee A; Leow WQ; Zhao JM; Rao HY; Wang XX; Wang Q; Wan WK; Lim KH; Romero-Gomez M; Petta S; Bugianesi E; Tan CK; Harrison SA; Anstee QM; Chang PJ; Wei L
    Hepatology; 2020 Jun; 71(6):1953-1966. PubMed ID: 31600834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
    Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.
    Vuppalanchi R; Unalp A; Van Natta ML; Cummings OW; Sandrasegaran KE; Hameed T; Tonascia J; Chalasani N
    Clin Gastroenterol Hepatol; 2009 Apr; 7(4):481-6. PubMed ID: 19162235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease.
    Neuschwander-Tetri BA; Clark JM; Bass NM; Van Natta ML; Unalp-Arida A; Tonascia J; Zein CO; Brunt EM; Kleiner DE; McCullough AJ; Sanyal AJ; Diehl AM; Lavine JE; Chalasani N; Kowdley KV;
    Hepatology; 2010 Sep; 52(3):913-24. PubMed ID: 20648476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.
    Ozenirler S; Erkan G; Konca Degertekin C; Ercin U; Cengiz M; Bilgihan A; Yilmaz G; Akyol G
    J Dig Dis; 2014 Mar; 15(3):131-6. PubMed ID: 24528633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathology of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB; Behling C; Newbury R; Deutsch R; Nievergelt C; Schork NJ; Lavine JE
    Hepatology; 2005 Sep; 42(3):641-9. PubMed ID: 16116629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers in nonalcoholic steatohepatitis.
    Armutcu F; Akyol S; Ucar F; Erdogan S; Akyol O
    Adv Clin Chem; 2013; 61():67-125. PubMed ID: 24015600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between endotoxemia and histological features of nonalcoholic fatty liver disease.
    Kitabatake H; Tanaka N; Fujimori N; Komatsu M; Okubo A; Kakegawa K; Kimura T; Sugiura A; Yamazaki T; Shibata S; Ichikawa Y; Joshita S; Umemura T; Matsumoto A; Koinuma M; Sano K; Aoyama T; Tanaka E
    World J Gastroenterol; 2017 Jan; 23(4):712-722. PubMed ID: 28216979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.
    Carter-Kent C; Yerian LM; Brunt EM; Angulo P; Kohli R; Ling SC; Xanthakos SA; Whitington PF; Charatcharoenwitthaya P; Yap J; Lopez R; McCullough AJ; Feldstein AE
    Hepatology; 2009 Oct; 50(4):1113-20. PubMed ID: 19637190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Brunt EM; Janney CG; Di Bisceglie AM; Neuschwander-Tetri BA; Bacon BR
    Am J Gastroenterol; 1999 Sep; 94(9):2467-74. PubMed ID: 10484010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
    Tandra S; Yeh MM; Brunt EM; Vuppalanchi R; Cummings OW; Ünalp-Arida A; Wilson LA; Chalasani N
    J Hepatol; 2011 Sep; 55(3):654-659. PubMed ID: 21172393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the histological variability of core and wedge biopsies in nonalcoholic fatty liver disease in bariatric surgical patients.
    Ooi GJ; Clouston A; Johari Y; Kemp WW; Roberts SK; Brown WA; Burton PR
    Surg Endosc; 2021 Mar; 35(3):1210-1218. PubMed ID: 32170564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.